www.fdanews.com/articles/159625-pharma-blog-watch
Pharma Blog Watch
October 2, 2013
Novartis Diovan Marketing May Have Violated Japanese Law (Pharmalot Blog)
Ed Silverman reports on a paper released by the Japanese health ministry claiming that Novartis violated the country’s laws by using faulty data in its marketing of Diovan. Authorities are soon likely to raid Novartis’ facilities in search of more evidence to support their case.
Ed Silverman reports on a paper released by the Japanese health ministry claiming that Novartis violated the country’s laws by using faulty data in its marketing of Diovan. Authorities are soon likely to raid Novartis’ facilities in search of more evidence to support their case.